REVAXIS is indicated for active immunisation against diphtheria, tetanus and poliomyelitis in children from six years of age, adolescents and adults as a booster following primary vaccination.
CALL US
0843 504 8147
Revaxis Diphtheria, Tetanus & Polio Combined Syringe *POM*
£23.81 + VAT
Lead time: 1 days
THIS PRODUCT IS A RESTRICTED ITEM. CONTACT US FOR MORE INFORMATION
Availability: In stock
£23.81 + VAT
RELATED ITEMS
-
-
Vivotif Oral Typhoid Vaccine Capsule -180mg (3) *POM*
£39.93 + VATPreventing typhoid in adults and children aged six years and over. This vaccine is not given routinely – it is recommended for people travelling to areas with a high risk of typhoid. -
-
Varilrix Vaccine (Chicken Pox) *POM*
£57.87 + VATVarilrix is indicated for active immunisation against varicella in healthy adults and adolescents (= 13 years) who have been found to be seronegative with respect to the varicella-zoster virus and are, therefore, at risk of developing chickenpox. -
Viatim Combined Hep A & Typhoid Vaccine Syringe *POM*
£93.64 + VATViATIM is indicated for simultaneous active immunisation against typhoid fever and hepatitis A virus infection in subjects from 16 years of age.ViATIM should be given in accordance with official recommendations. -
-
Revaxis Diphtheria, Tetanus & Polio Combined Syringe *POM*
£23.81 + VATREVAXIS is indicated for active immunisation against diphtheria, tetanus and poliomyelitis in children from six years of age, adolescents and adults as a booster following primary vaccination. -
Ixiaro Jap B Encephalitis Syringe – 0.5ml *POM*
£172.32 + VATIXIARO is indicated for active immunization against Japanese encephalitis in adults.IXIARO should be considered for use in individuals at risk of exposure through travel or in the course of their occupation.
